Barclays’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Sell |
26,439
-168,606
| -86% | -$153K | ﹤0.01% | 4066 |
|
|
2025
Q1 | $89K | Sell |
195,045
-39,024
| -17% | -$17.8K | ﹤0.01% | 3730 |
|
|
2024
Q4 | $118K | Buy |
234,069
+22,769
| +11% | +$11.5K | ﹤0.01% | 3760 |
|
|
2024
Q3 | $192K | Buy |
211,300
+159,924
| +311% | +$145K | ﹤0.01% | 3507 |
|
|
2024
Q2 | $51K | Sell |
51,376
-42,551
| -45% | -$42.2K | ﹤0.01% | 3673 |
|
|
2024
Q1 | $139K | Sell |
93,927
-89,365
| -49% | -$132K | ﹤0.01% | 3513 |
|
|
2023
Q4 | $200K | Buy |
183,292
+159,296
| +664% | +$174K | ﹤0.01% | 3506 |
|
|
2023
Q3 | $28K | Sell |
23,996
-1,909
| -7% | -$2.23K | ﹤0.01% | 3806 |
|
|
2023
Q2 | $36K | Buy |
25,905
+12,075
| +87% | +$16.8K | ﹤0.01% | 3806 |
|
|
2023
Q1 | $21K | Sell |
13,830
-14,279
| -51% | -$21.7K | ﹤0.01% | 3988 |
|
|
2022
Q4 | $33K | Buy |
28,109
+20,472
| +268% | +$24K | ﹤0.01% | 3908 |
|
|
2022
Q3 | $9K | Buy |
+7,637
| New | +$9K | ﹤0.01% | 4231 |
|
|
2022
Q2 | – | Sell |
-20,360
| Closed | -$31K | – | 4827 |
|
|
2022
Q1 | $31K | Buy |
+20,360
| New | +$31K | ﹤0.01% | 4184 |
|
|
2019
Q3 | – | Sell |
-71,999
| Closed | -$79K | – | 4281 |
|
|
2019
Q2 | $79K | Buy |
71,999
+39,757
| +123% | +$43.6K | ﹤0.01% | 3689 |
|
|
2019
Q1 | $42K | Buy |
32,242
+30,862
| +2,236% | +$40.2K | ﹤0.01% | 3716 |
|
|
2018
Q4 | $1K | Sell |
1,380
-44,111
| -97% | -$32K | ﹤0.01% | 4004 |
|
|
2018
Q3 | $93K | Buy |
45,491
+31,940
| +236% | +$65.3K | ﹤0.01% | 3449 |
|
|
2018
Q2 | $25K | Sell |
13,551
-70,956
| -84% | -$131K | ﹤0.01% | 3543 |
|
|
2018
Q1 | $199K | Buy |
84,507
+4,914
| +6% | +$11.6K | ﹤0.01% | 2843 |
|
|
2017
Q4 | $150K | Buy |
79,593
+76,447
| +2,430% | +$144K | ﹤0.01% | 2813 |
|
|
2017
Q3 | $8K | Buy |
3,146
+1,942
| +161% | +$4.94K | ﹤0.01% | 3505 |
|
|
2017
Q2 | $3K | Sell |
1,204
-1,479
| -55% | -$3.69K | ﹤0.01% | 3628 |
|
|
2017
Q1 | $7K | Buy |
2,683
+464
| +21% | +$1.21K | ﹤0.01% | 3593 |
|
|
2016
Q4 | $6K | Sell |
2,219
-749
| -25% | -$2.03K | ﹤0.01% | 3393 |
|
|
2016
Q3 | $11K | Buy |
2,968
+1,827
| +160% | +$6.77K | ﹤0.01% | 3227 |
|
|
2016
Q2 | $2K | Hold |
1,141
| – | – | ﹤0.01% | 3287 |
|
|
2016
Q1 | $2K | Sell |
1,141
-5,210
| -82% | -$9.13K | ﹤0.01% | 3211 |
|
|
2015
Q4 | $21K | Buy |
6,351
+3,529
| +125% | +$11.7K | ﹤0.01% | 2687 |
|
|
2015
Q3 | $7K | Sell |
2,822
-27,279
| -91% | -$67.7K | ﹤0.01% | 3185 |
|
|
2015
Q2 | $73K | Sell |
30,101
-31,096
| -51% | -$75.4K | ﹤0.01% | 2486 |
|
|
2015
Q1 | $197K | Buy |
61,197
+54,805
| +857% | +$176K | ﹤0.01% | 2271 |
|
|
2014
Q4 | $16K | Sell |
6,392
-397
| -6% | -$994 | ﹤0.01% | 3511 |
|
|
2014
Q3 | $17K | Sell |
6,789
-10,340
| -60% | -$25.9K | ﹤0.01% | 3491 |
|
|
2014
Q2 | $42K | Buy |
17,129
+4,833
| +39% | +$11.9K | ﹤0.01% | 3122 |
|
|
2014
Q1 | $29K | Buy |
12,296
+167
| +1% | +$394 | ﹤0.01% | 3415 |
|
|
2013
Q4 | $29K | Sell |
12,129
-1,313
| -10% | -$3.14K | ﹤0.01% | 3600 |
|
|
2013
Q3 | $32K | Buy |
13,442
+2,368
| +21% | +$5.64K | ﹤0.01% | 3347 |
|
|
2013
Q2 | $36K | Buy |
+11,074
| New | +$36K | ﹤0.01% | 3476 |
|